Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Larotrectinib phase 1–2 study in Japan
jRCT2080224765Phase 2Completed
- Start
- Jul 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
01
Overview
Phase 2, single-arm trial of larotrectinib in Nonhematologic neoplasms. Started Jul 2019; status: completed.
02
Drugs
larotrectinib
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080224765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224765.